4CPS-242 Regulatory validation of prescriptions at a teaching hospital. (March 2019)

• Record Type: Journal Article
• Authors: Mseddi, M; Myriam, K; Hamdi, A; Manel, T
• Is Part Of: European journal of hospital pharmacy. Volume 26(2019)Supplement 1
• Page Start: A182
• Page End: A182
• Publication Date: 2019-03
• Subjects: Pharmacy -- Periodicals; Hospital pharmacies -- Periodicals; 615.1
• DOI: 10.1136/ejhpharm-2019-eahpconf.391
• Languages: English
• ISSNs: 2047-9956

Abstract

Abstract : Background: Regulatory compliance of prescriptions is a key aspect of good performance of pharmaceutical validation within the hospital. Several irregularities have been detected in daily practice. Purpose: Estimate the nature and prevalence of irregularities in prescriptions at a teaching hospital's pharmacy in order to establish an action plan. Material and methods: A one-day study (October 2017) conducted on all (out/in) patients' prescriptions at the teaching hospital. The patient registration number was verified systematically via a dedicated software ADMIS. The quantitative and qualitative analysis of prescriptions was done via SPSS software v23. The analysis of multivariate data was made by Kiviat Diagrams. Results: The analysis was based on 590 prescriptions, of which 393 were from the external pharmacy and 197 from hospitalised patients. The prescriptions were completely delivered in 80% of the cases. Ninety-five per cent of the validated prescriptions pharmaceutically were from the hospitalised services against 73.7% for prescriptions resulting from the consulting services. All the prescriptions bore the correct registration number corresponding to the right patient, and treatment duration was present in 100% of the cases. The non-conformity (absence/illegibility) was due to the prescriber's stamp in 11.9%, the date of prescription in 3.1% of cases and the seal of the service in 7.5% of all cases corresponding to 11% of outpatients. The origin of the non-compliance issued mainly from the haematology department (11.4%), followed by cardiology (10.5%) and endocrinology (8.8%), and in 25% of cases the service was unidentifiable. This critical analysis of the regulatory aspect allowed us to identify several causes requiring a plan of action, mainly: non-availability of the stamps of some freshly graduated doctors; the ink was not available; superimposition of service and prescribing stamps; and forgetting the stamp on the prescription. Consequently, official letters were sent to all physicians reminding them about regulatory requirements for medical prescribing. An evaluation is planned within a year. Conclusion: Regulatory validation of prescriptions is a preliminary and essential step in pharmaceutical validation. A critical analysis of the irregularities makes it possible to establish a plan of action with specific procedures and proves periodically necessary as an indicator of the good functioning of the system. References and/or acknowledgements: No conflict of interest.